94.5% survival in childhood cancer, says study; flags late risks, Pg12

Key Highlights:

• A nationwide registry tracking childhood cancer survivors in India reports a 94.5% five-year overall survival rate.
• The study, published in The Lancet Regional Health Southeast Asia, is based on data from 5,419 survivors across 20 centers.
• The Indian Childhood Cancer Survivorship (C2S) cohort study was initiated in 2016 by the Indian National Pediatric Oncology Group.
• Event-free survival was 89.9% at five years, rising to 95.7% among survivors followed for at least two years after treatment.

Detailed Insights:

• The C2S cohort aims to understand the long-term outcomes for children after completing cancer treatment, focusing on late effects and long-term morbidities.
• Participants were monitored every three months for the first two years and every six months thereafter to assess growth, puberty, schooling, and symptoms.
• The study highlights that a significant proportion of childhood cancer survivors may experience long-term complications, such as heart problems, hormonal disorders, and learning difficulties.
• The cohort will serve as a foundation for future research on late effects, aiding in the development of survivorship guidelines and informing policy planning in India and similar Low- and Middle-Income Countries (LMIC).

Key Concepts Involved:

• Overall Survival: The percentage of people in a study who are still alive for a certain period of time after they were diagnosed with a disease.
• Event-Free Survival: The length of time after treatment during which the cancer being studied does not come back or get worse.
• Late Effects: Side effects of cancer treatment that occur months or years after treatment has ended.